多重耐药鲍曼不动杆菌感染的药物治疗进展

Progress in drug therapy for multidrug-resistant Acinetobacter baumannii infection

鲍曼不动杆菌是引起呼吸道、血流、泌尿道及腹腔等多部位感染的常见病原体。近几年鲍曼不动杆菌对临床常用药物的耐药率逐年上升,已有报道多重耐药、广泛耐药甚至全耐药菌株在世界各地广泛传播,给临床治疗带来极大的挑战。因此,本文旨在对多重耐药鲍曼不动杆菌的药物治疗及最新进展加以综述。

Acinetobacter baumannii is a common pathogen that causes infections in the respiratory tract, blood flow, urinary tract and abdominal cavity. In recent years, the drug resistance rate of Acinetobacter baumannii to commonly used clinical drugs has increased year by year. It has been reported that multidrug-resistant, extensively drug-resistance and even pandrug-resistance strains are widely spread all over the world, which brings great challenges to clinical treatment. Therefore, the purpose of this paper is to review the drug treatment and the latest progress of multi-drug-resistant Acinetobacter baumannii.